176 related articles for article (PubMed ID: 32437446)
1. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
2. Significance of
Lin H; Wang J; Shi Q; Wu M
PeerJ; 2024; 12():e17338. PubMed ID: 38708353
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma.
Koh YW; Han JH; Haam S; Lee HW
Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
[TBL] [Abstract][Full Text] [Related]
4. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
5. Potential applications of prognostic and immunological marker transmembrane serine proteinase 2 in prediction, prevention and personalized treatment of lung cancer.
Mu B; Zhang R; Pu Y; Yao J; Hu X; Zhao C
Eur J Cancer Prev; 2023 Jan; 32(1):65-68. PubMed ID: 35170548
[TBL] [Abstract][Full Text] [Related]
6. Discriminative and prognostic significance of LINC00623 for lung adenocarcinoma.
Lin Y; Dong C; Zhang J; Zhu Y
Ann Biol Clin (Paris); 2024 Feb; 81(6):591-601. PubMed ID: 38391164
[TBL] [Abstract][Full Text] [Related]
7. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Yin D; Zhang Y; Li H; Cheng L
Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
[TBL] [Abstract][Full Text] [Related]
8. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
9. Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers.
Chen M; Liu X; Du J; Wang XJ; Xia L
Oncotarget; 2017 Jan; 8(1):133-144. PubMed ID: 27863400
[TBL] [Abstract][Full Text] [Related]
10. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.
Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S
Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401
[TBL] [Abstract][Full Text] [Related]
11. Identification of
Bian T; Zhang W; Wang F; Chu X; Pan X; Ruan J; Yu S; Liu L; Sun H; Qiu H; Li Y; Tang J; Zhao X; Zhang H
Comb Chem High Throughput Screen; 2023; 26(14):2452-2468. PubMed ID: 37038295
[TBL] [Abstract][Full Text] [Related]
12. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Cao B; Wang P; Gu L; Liu J
Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813
[TBL] [Abstract][Full Text] [Related]
13. GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma.
Yan G; Li G; Gao X; Liu J; Li Y; Li J; Zhou H
Clin Respir J; 2024 May; 18(5):e13757. PubMed ID: 38715380
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Zengin T; Önal-Süzek T
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117
[TBL] [Abstract][Full Text] [Related]
15. TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.
Cheng L; Han T; Chen B; Nie K; Peng W
BMC Cancer; 2021 Jul; 21(1):794. PubMed ID: 34238250
[TBL] [Abstract][Full Text] [Related]
16. Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response.
Lucchetta M; da Piedade I; Mounir M; Vabistsevits M; Terkelsen T; Papaleo E
BMC Cancer; 2019 Aug; 19(1):824. PubMed ID: 31429720
[TBL] [Abstract][Full Text] [Related]
17. CRTAC1 identified as a promising diagnosis and prognostic biomarker in lung adenocarcinoma.
Tan L; Zhang H; Ding Y; Huang Y; Sun D
Sci Rep; 2024 May; 14(1):11223. PubMed ID: 38755183
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
19. Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
Kosai K; Masuda T; Kitagawa A; Tobo T; Ono Y; Ando Y; Takahashi J; Haratake N; Kohno M; Takenaka T; Yoshizumi T; Mimori K
Ann Surg Oncol; 2023 Nov; 30(12):7538-7548. PubMed ID: 37477745
[TBL] [Abstract][Full Text] [Related]
20. Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma.
Tuna M; Mills GB; Amos CI
Neoplasia; 2023 Nov; 45():100932. PubMed ID: 37801862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]